Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

LFST LifeStance Health Group Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFST

Price (delayed)

$4.79

Market cap

$1.86B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$2.2B

Highlights
LFST's net income has soared by 79% YoY and by 38% from the previous quarter
LFST's EPS has surged by 79% year-on-year and by 33% since the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities

Key stats

What are the main financial stats of LFST
Market
Shares outstanding
388.88M
Market cap
$1.86B
Enterprise value
$2.2B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.26
Price to sales (P/S)
1.43
EV/EBIT
N/A
EV/EBITDA
25.15
EV/Sales
1.72
Earnings
Revenue
$1.28B
Gross profit
$417.46M
Operating income
-$13.24M
Net income
-$35.64M
EBIT
-$14.64M
EBITDA
$87.54M
Free cash flow
$102.38M
Per share
EPS
-$0.1
EPS diluted
-$0.1
Free cash flow per share
$0.27
Book value per share
$3.79
Revenue per share
$3.35
TBVPS
$1.63
Balance sheet
Total assets
$2.1B
Total liabilities
$647.57M
Debt
$473.01M
Equity
$1.46B
Working capital
$97.25M
Liquidity
Debt to equity
0.32
Current ratio
1.47
Quick ratio
1.32
Net debt/EBITDA
3.87
Margins
EBITDA margin
6.8%
Gross margin
32.5%
Net margin
-2.8%
Operating margin
-1%
Efficiency
Return on assets
-1.7%
Return on equity
-2.5%
Return on invested capital
-1.9%
Return on capital employed
-0.8%
Return on sales
-1.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFST stock price

How has the LifeStance Health Group stock price performed over time
Intraday
0.31%
1 week
-5.71%
1 month
-19.63%
1 year
-5.52%
YTD
-35.01%
QTD
-7.35%

Financial performance

How have LifeStance Health Group's revenue and profit performed over time
Revenue
$1.28B
Gross profit
$417.46M
Operating income
-$13.24M
Net income
-$35.64M
Gross margin
32.5%
Net margin
-2.8%
The operating margin has surged by 94% year-on-year and by 60% since the previous quarter
The operating income has surged by 92% year-on-year and by 58% since the previous quarter
The net margin has soared by 82% YoY and by 39% from the previous quarter
LFST's net income has soared by 79% YoY and by 38% from the previous quarter

Price vs fundamentals

How does LFST's price correlate with its fundamentals

Growth

What is LifeStance Health Group's growth rate over time

Valuation

What is LifeStance Health Group stock price valuation
P/E
N/A
P/B
1.26
P/S
1.43
EV/EBIT
N/A
EV/EBITDA
25.15
EV/Sales
1.72
LFST's EPS has surged by 79% year-on-year and by 33% since the previous quarter
LFST's price to book (P/B) is 43% lower than its 5-year quarterly average of 2.2 and 26% lower than its last 4 quarters average of 1.7
The price to sales (P/S) is 29% less than the last 4 quarters average of 2.0
The revenue has grown by 16% YoY and by 2.6% from the previous quarter

Efficiency

How efficient is LifeStance Health Group business performance
LFST's return on sales has surged by 93% year-on-year and by 56% since the previous quarter
LFST's return on invested capital has surged by 90% year-on-year and by 51% since the previous quarter
LifeStance Health Group's return on equity has surged by 79% YoY and by 38% QoQ
LifeStance Health Group's return on assets has surged by 79% YoY and by 37% QoQ

Dividends

What is LFST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFST.

Financial health

How did LifeStance Health Group financials performed over time
LFST's current ratio is up by 25% YoY and by 7% QoQ
The quick ratio has grown by 21% YoY and by 6% from the previous quarter
The debt is 68% less than the equity
The debt to equity has contracted by 9% YoY and by 3% from the previous quarter
The debt has contracted by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.